r&d

Over the past two decades, business has done most of the heavy lifting for research and development (R&D) funding. Calculated in the dollar value of 2012, business funding increased from $10.4 billion in 2000 to an estimated $36.0 billion in 2021.

The National Center for Science and Engineering Statistics (NCSES) keeps track of these types of statistics, and the above data is from Business Sector Increases Funding for Basic Research, one of three InfoCharts released last month.

The National Science Foundation (NSF) is expanding a network of research centers across the country to translate university-based R&D into new, and hopefully, better advanced materials. In late June, NSF announced the distribution of $162 million to support the creation of nine more Materials Research Science & Engineering Centers (MRSECs), bringing the total number of centers to twenty. Each of the new centers will receive $18 million over six years.

The House and Senate are working toward FY 2024 appropriations, but not even a negotiated agreement has kept the chambers moving in the same direction. Today, the Senate appropriations committee directed its subcommittees to produce bills that align with the slight reduction in non-defense spending agreed to in the debt ceiling agreement reached earlier this month.

Under Secretary of Commerce for Standards and Technology and National Institute of Standards and Technology (NIST) Director Laurie E. Locascio announced five leaders joining the CHIPS Research and Development Office within CHIPS for America.

Corporate laboratories were hotspots for U.S. innovation for most of the twentieth century. Large firms, such as DuPont or Bell Labs, acted as epicenters for research and development activities, driving investment in frontier technologies underserved by university researchers at the time. By the 1980s, however, many of these powerhouses of industrial research began to cut back on their research programs, paving the way for universities and startups to emerge as new centers of innovation.

While the Tax Cuts and Jobs Act of 2017 was passed more than five years ago, many businesses seem to be just discovering the effects of one of its sections this tax season. The law stipulated that, for tax years beginning in 2022, companies could no longer choose to expense their entire “research and experimentation” costs in one year and must instead amortize those cost over five years (with a half year look-back).

A new report compiled by The White House Office of Science and Technology Policy (OSTP) outlines a whole-of-government approach to biotechnology and making it a national priority.

Western democracies are losing the race for scientific and research breakthroughs, and the ability to retain global talent, integral ingredients in developing technologies, according to a recent report from the Australian Strategic Policy Institute (ASPI). In the project funded by the U.S.

The U.S. National Science Foundation announced a new $60 million investment led by NSF's Directorate for Technology, Innovation and Partnerships — the Accelerating Research Translation, or ART, program. The program will build capacity and infrastructure at higher education institutions that are needed to strengthen and scale the translation of basic research outcomes into impactful solutions and practice.

Microbusinesses (businesses with 1-9 domestic employees) spent $7.5 billion in both domestic and foreign R&D expenditures or costs in 2020, of which $6.7 billion was in the U.S. Of this total, $5.6 billion was performed by microbusinesses themselves, according to the National Center for Science and Engineering Statistics (NCSES) and data from the Annual Business Survey (ABS). The $5.6 billion performed by U.S.